“COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS”, IJITSS, vol. 1, no. 1(49), Jan. 2026, doi: 10.31435/ijitss.1(49).2026.4695.